Venous thromboembolism

Courtney Lyle, Neil Goldenberg

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Venous thrombotic disease is a serious concern for critically ill children hospitalized in the intensive care and cardiac intensive care units. Children with both innate and acquired conditions, including cardiac disease, a central venous catheter, immobility, a postoperative state, malignancy, an infectious or inflammatory state, traumatic injuries, or a disturbance of the coagulation pathway, may suffer from a venous thromboembolism during their hospitalization. As children suffer from both acute and chronic morbidity as well as a heightened risk of death following venous thromboembolism, it is essential that clinicians consider the latter as a possible complication during an intensive care admission. Treatment of venous thromboembolism in the acute period includes the use of anticoagulants, thrombolytic agents, mechanical and surgical thrombectomy, vena caval filters, and, in rare cases, observation and supportive care alone. In the child with congenital or acquired cardiac disease, the modality of treatment is dependent upon many considerations. Among these are the severity and location of the venous thromboembolism, the anatomy and physiology of the child, as well as the surgical and intervention history, and the clinical stability of the patient. Chronic therapy is considered to prevent recurrent events and embolization from residual thrombus. Although prevention strategies are imperative to decrease the incidence of venous thromboembolism, there is no consensus in the pediatric literature to inform optimal thromboprophylaxis guidelines. In general, thromboprophylaxis is prescribed for children with cardiac disease requiring palliative or corrective surgery, endovascular stents, bioprosthetic or mechanical valves, cardiac catheterization, or cardiac transplant as they are at greatest risk of developing venous thromboembolism. Further inquiry must be undertaken to determine the safety and benefit of thromboprophylaxis for other critically ill children in the intensive care with multiple risk factors.

Original languageEnglish (US)
Title of host publicationPediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care
PublisherSpringer-Verlag London Ltd
Pages3235-3255
Number of pages21
ISBN (Print)9781447146193, 9781447146186
DOIs
StatePublished - Jan 1 2014

Fingerprint

Venous Thromboembolism
Critical Care
Heart Diseases
Critical Illness
Thrombectomy
Venae Cavae
Hospitalized Child
Fibrinolytic Agents
Central Venous Catheters
Cardiac Catheterization
Anticoagulants
Stents
Intensive Care Units
Anatomy
Hospitalization
Thrombosis
Therapeutics
History
Observation
Guidelines

Keywords

  • Anticoagulation
  • Catheter
  • Child
  • Inflammation
  • Malignancy
  • Mortality
  • Pediatric
  • Pediatric cardiology
  • Pediatric intensive care
  • Percutaneous mechanical thrombolysis
  • Post-thrombotic syndrome
  • Pulmonary embolus
  • Thrombectomy
  • Thromboembolism
  • Thrombolysis
  • Thromboprophylaxis
  • Trauma
  • Vena caval filter
  • Venous thrombosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lyle, C., & Goldenberg, N. (2014). Venous thromboembolism. In Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care (pp. 3235-3255). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-4619-3_166

Venous thromboembolism. / Lyle, Courtney; Goldenberg, Neil.

Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer-Verlag London Ltd, 2014. p. 3235-3255.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lyle, C & Goldenberg, N 2014, Venous thromboembolism. in Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer-Verlag London Ltd, pp. 3235-3255. https://doi.org/10.1007/978-1-4471-4619-3_166
Lyle C, Goldenberg N. Venous thromboembolism. In Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer-Verlag London Ltd. 2014. p. 3235-3255 https://doi.org/10.1007/978-1-4471-4619-3_166
Lyle, Courtney ; Goldenberg, Neil. / Venous thromboembolism. Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer-Verlag London Ltd, 2014. pp. 3235-3255
@inbook{fe4ef238657e444789a18df4fb7e5129,
title = "Venous thromboembolism",
abstract = "Venous thrombotic disease is a serious concern for critically ill children hospitalized in the intensive care and cardiac intensive care units. Children with both innate and acquired conditions, including cardiac disease, a central venous catheter, immobility, a postoperative state, malignancy, an infectious or inflammatory state, traumatic injuries, or a disturbance of the coagulation pathway, may suffer from a venous thromboembolism during their hospitalization. As children suffer from both acute and chronic morbidity as well as a heightened risk of death following venous thromboembolism, it is essential that clinicians consider the latter as a possible complication during an intensive care admission. Treatment of venous thromboembolism in the acute period includes the use of anticoagulants, thrombolytic agents, mechanical and surgical thrombectomy, vena caval filters, and, in rare cases, observation and supportive care alone. In the child with congenital or acquired cardiac disease, the modality of treatment is dependent upon many considerations. Among these are the severity and location of the venous thromboembolism, the anatomy and physiology of the child, as well as the surgical and intervention history, and the clinical stability of the patient. Chronic therapy is considered to prevent recurrent events and embolization from residual thrombus. Although prevention strategies are imperative to decrease the incidence of venous thromboembolism, there is no consensus in the pediatric literature to inform optimal thromboprophylaxis guidelines. In general, thromboprophylaxis is prescribed for children with cardiac disease requiring palliative or corrective surgery, endovascular stents, bioprosthetic or mechanical valves, cardiac catheterization, or cardiac transplant as they are at greatest risk of developing venous thromboembolism. Further inquiry must be undertaken to determine the safety and benefit of thromboprophylaxis for other critically ill children in the intensive care with multiple risk factors.",
keywords = "Anticoagulation, Catheter, Child, Inflammation, Malignancy, Mortality, Pediatric, Pediatric cardiology, Pediatric intensive care, Percutaneous mechanical thrombolysis, Post-thrombotic syndrome, Pulmonary embolus, Thrombectomy, Thromboembolism, Thrombolysis, Thromboprophylaxis, Trauma, Vena caval filter, Venous thrombosis",
author = "Courtney Lyle and Neil Goldenberg",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-4619-3_166",
language = "English (US)",
isbn = "9781447146193",
pages = "3235--3255",
booktitle = "Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Venous thromboembolism

AU - Lyle, Courtney

AU - Goldenberg, Neil

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Venous thrombotic disease is a serious concern for critically ill children hospitalized in the intensive care and cardiac intensive care units. Children with both innate and acquired conditions, including cardiac disease, a central venous catheter, immobility, a postoperative state, malignancy, an infectious or inflammatory state, traumatic injuries, or a disturbance of the coagulation pathway, may suffer from a venous thromboembolism during their hospitalization. As children suffer from both acute and chronic morbidity as well as a heightened risk of death following venous thromboembolism, it is essential that clinicians consider the latter as a possible complication during an intensive care admission. Treatment of venous thromboembolism in the acute period includes the use of anticoagulants, thrombolytic agents, mechanical and surgical thrombectomy, vena caval filters, and, in rare cases, observation and supportive care alone. In the child with congenital or acquired cardiac disease, the modality of treatment is dependent upon many considerations. Among these are the severity and location of the venous thromboembolism, the anatomy and physiology of the child, as well as the surgical and intervention history, and the clinical stability of the patient. Chronic therapy is considered to prevent recurrent events and embolization from residual thrombus. Although prevention strategies are imperative to decrease the incidence of venous thromboembolism, there is no consensus in the pediatric literature to inform optimal thromboprophylaxis guidelines. In general, thromboprophylaxis is prescribed for children with cardiac disease requiring palliative or corrective surgery, endovascular stents, bioprosthetic or mechanical valves, cardiac catheterization, or cardiac transplant as they are at greatest risk of developing venous thromboembolism. Further inquiry must be undertaken to determine the safety and benefit of thromboprophylaxis for other critically ill children in the intensive care with multiple risk factors.

AB - Venous thrombotic disease is a serious concern for critically ill children hospitalized in the intensive care and cardiac intensive care units. Children with both innate and acquired conditions, including cardiac disease, a central venous catheter, immobility, a postoperative state, malignancy, an infectious or inflammatory state, traumatic injuries, or a disturbance of the coagulation pathway, may suffer from a venous thromboembolism during their hospitalization. As children suffer from both acute and chronic morbidity as well as a heightened risk of death following venous thromboembolism, it is essential that clinicians consider the latter as a possible complication during an intensive care admission. Treatment of venous thromboembolism in the acute period includes the use of anticoagulants, thrombolytic agents, mechanical and surgical thrombectomy, vena caval filters, and, in rare cases, observation and supportive care alone. In the child with congenital or acquired cardiac disease, the modality of treatment is dependent upon many considerations. Among these are the severity and location of the venous thromboembolism, the anatomy and physiology of the child, as well as the surgical and intervention history, and the clinical stability of the patient. Chronic therapy is considered to prevent recurrent events and embolization from residual thrombus. Although prevention strategies are imperative to decrease the incidence of venous thromboembolism, there is no consensus in the pediatric literature to inform optimal thromboprophylaxis guidelines. In general, thromboprophylaxis is prescribed for children with cardiac disease requiring palliative or corrective surgery, endovascular stents, bioprosthetic or mechanical valves, cardiac catheterization, or cardiac transplant as they are at greatest risk of developing venous thromboembolism. Further inquiry must be undertaken to determine the safety and benefit of thromboprophylaxis for other critically ill children in the intensive care with multiple risk factors.

KW - Anticoagulation

KW - Catheter

KW - Child

KW - Inflammation

KW - Malignancy

KW - Mortality

KW - Pediatric

KW - Pediatric cardiology

KW - Pediatric intensive care

KW - Percutaneous mechanical thrombolysis

KW - Post-thrombotic syndrome

KW - Pulmonary embolus

KW - Thrombectomy

KW - Thromboembolism

KW - Thrombolysis

KW - Thromboprophylaxis

KW - Trauma

KW - Vena caval filter

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84956513848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956513848&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-4619-3_166

DO - 10.1007/978-1-4471-4619-3_166

M3 - Chapter

AN - SCOPUS:84956513848

SN - 9781447146193

SN - 9781447146186

SP - 3235

EP - 3255

BT - Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care

PB - Springer-Verlag London Ltd

ER -